12:00 AM
 | 
Sep 18, 2006
 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changest

Analyst picks & changest

Company Bank Analyst Coverage Opinion Wk chg 9/15 cls
Aastrom (ASTM) Rodman Ren Benjamin Price target Market outperform 15% $1.32
Benjamin lowered his target to $2 from $3, citing lower valuations for biotech companies developing stem cell therapeutics. He did note that ASTM still trades at a discount to its peers and reiterated his "outperform" rating.
Discovery Partners (DPII) Cowen Phil Nadeau Discontinued NA NA NA
The firm discontinued coverage after DPII completed a merger with cancer company Infinity (INFI) (see...

Read the full 535 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >